{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:01:08Z","timestamp":1764028868264,"version":"3.45.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejso.2025.110496","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:44:28Z","timestamp":1760071468000},"page":"110496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis"],"prefix":"10.1016","volume":"51","author":[{"given":"Yali","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qindong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunguo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangmeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-0788","authenticated-orcid":false,"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2025.110496_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","article-title":"Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2025.110496_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.breast.2023.01.001","article-title":"A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis","volume":"67","author":"Li","year":"2023","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2025.110496_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25118","article-title":"Comparison of use of neoadjuvant systemic treatment for breast cancer and short-term outcomes before vs during the COVID-19 era in Ontario, Canada","volume":"5","author":"Habbous","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2025.110496_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000793","article-title":"ESMO management and treatment adapted recommendations in the COVID-19 era: Breast cancer","volume":"5","author":"de Azambuja","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejso.2025.110496_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/bjs.4840","article-title":"Neoadjuvant chemotherapy in breast cancer","volume":"92","author":"Charfare","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2025.110496_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(21)00589-1","article-title":"Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.110496_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.110496_bib8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2025.110496_bib9","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2016.15865","article-title":"Effect of tailored dose-dense chemotherapy vs standard 3-Weekly adjuvant chemotherapy on recurrence-free survival among women with high-risk early breast cancer: a randomized clinical trial","volume":"316","author":"Foukakis","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2025.110496_bib10","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1158\/1078-0432.CCR-21-1133","article-title":"A neoadjuvant chemotherapy trial for early breast cancer is impacted by COVID-19: addressing vaccination and cancer trials through education, equity, and outcomes","volume":"27","author":"Potter","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2025.110496_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41416-024-02703-w","article-title":"Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland - a scoping review","volume":"131","author":"Lohfeld","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2025.110496_bib12","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/jnci\/djab097","article-title":"Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling","volume":"113","author":"Alagoz","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2025.110496_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-021-01363-1","article-title":"The intersection of COVID-19 and cancer: signaling pathways and treatment implications","volume":"20","author":"Zong","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejso.2025.110496_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cell.2020.09.005","article-title":"Cancer, COVID-19, and antiviral immunity: the CAPTURE study","volume":"183","author":"Au","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejso.2025.110496_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cytogfr.2021.10.005","article-title":"Cancer and Covid-19: collectively catastrophic","volume":"63","author":"du Plessis","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ejso.2025.110496_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13058-020-01360-0","article-title":"COVID-19: a potential driver of immune-mediated breast cancer recurrence?","volume":"22","author":"Francescangeli","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2025.110496_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s43018-020-00122-3","article-title":"The immuno-oncological challenge of COVID-19","volume":"1","author":"Derosa","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejso.2025.110496_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1158\/2159-8290.CD-20-0559","article-title":"The landscape of human cancer proteins targeted by SARS-CoV-2","volume":"10","author":"Tutuncuoglu","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ejso.2025.110496_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2025.110496_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ejso.2025.110496_bib21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.drudis.2021.01.002","article-title":"Tumor-infiltrating CD8(+) T cell antitumor efficacy and exhaustion: molecular insights","volume":"26","author":"Kumar","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ejso.2025.110496_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(23)00213-1","article-title":"China's COVID-19 reopening measures-warriors and weapons","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2025.110496_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejso.2025.110496_bib24","article-title":"Response to treatment, racial and ethnic disparity, and survival in patients with breast cancer undergoing neoadjuvant chemotherapy in the US, JAMA netw","volume":"6","author":"Shubeck","year":"2023","journal-title":"Open"},{"key":"10.1016\/j.ejso.2025.110496_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12967-023-04110-w","article-title":"Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment","volume":"21","author":"Meo","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejso.2025.110496_bib26","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3390\/curroncol28050294","article-title":"Spontaneous regression of metastatic renal cell carcinoma after SARS-CoV-2 infection: a report of two cases","volume":"28","author":"Buchler","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2025.110496_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.17116","article-title":"SARS-CoV-2-induced remission of hodgkin lymphoma","volume":"192","author":"Challenor","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejso.2025.110496_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ejso.2025.110496_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1174184","article-title":"Add fuel to the fire: inflammation and immune response in lung cancer combined with COVID-19","volume":"14","author":"Ai","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejso.2025.110496_bib30","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ejso.2025.110496_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41421-018-0040-3","article-title":"abLIM1 constructs non-erythroid cortical actin networks to prevent mechanical tension-induced blebbing","volume":"4","author":"Li","year":"2018","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejso.2025.110496_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2025.110496_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/JCMA.0000000000001203","article-title":"Predictive biosignatures for hospitalization in patients with virologically confirmed COVID-19","volume":"88","author":"Liang","year":"2025","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.ejso.2025.110496_bib34","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.7150\/ijbs.46285","article-title":"Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in hepatocellular carcinoma","volume":"16","author":"Dong","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ejso.2025.110496_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41418-024-01256-y","article-title":"ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting I\u0138B\u03b1 ubiquitination and activating NF-\u0138B signaling","volume":"31","author":"He","year":"2024","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ejso.2025.110496_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112077","article-title":"ABLIM1 promotes the proliferation, migration and invasion of osteosarcoma through DCC mediated activation of PI3K\/AKT signaling pathway","volume":"135","author":"Liao","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.ejso.2025.110496_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-018-9192-2","article-title":"The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature","volume":"15","author":"Chauvin","year":"2018","journal-title":"Clin Proteom"},{"key":"10.1016\/j.ejso.2025.110496_bib38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","article-title":"A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients","volume":"7","author":"Cursons","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ejso.2025.110496_bib39","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1158\/1078-0432.CCR-15-0685","article-title":"How do cytotoxic lymphocytes kill cancer cells?","volume":"21","author":"Mart\u00ednez-Lostao","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2025.110496_bib40","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-22-0543","article-title":"Dynamic changes in the NK-, Neutrophil-, and B-cell immunophenotypes relevant in high metastatic risk post neoadjuvant chemotherapy\u2013resistant early breast cancers","volume":"28","author":"Gazinska","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2025.110496_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/cas.15224","article-title":"Decreased expression of T\u2010cell\u2010associated immune markers predicts poor prognosis in patients with follicular lymphoma","volume":"113","author":"Rai","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2025.110496_bib42","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2024.35.e8","article-title":"Identification of the prognostic immune subtype in copy-number high endometrial cancer","volume":"35","author":"Mao","year":"2024","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejso.2025.110496_bib43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4048\/jbc.2023.0299","article-title":"Neoadjuvant chemotherapy is effective in those infected with SARS-CoV-2: the real-world experience of a large Chinese breast cancer center","volume":"27","author":"Ma","year":"2024","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.ejso.2025.110496_bib44","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1158\/1078-0432.CCR-19-0560","article-title":"Prognostic value of residual disease after neoadjuvant therapy in HER2-Positive breast cancer evaluated by residual cancer burden, neoadjuvant response index, and neo-bioscore","volume":"25","author":"Steenbruggen","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T23:56:18Z","timestamp":1764028578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0748798325009242"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110496","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110496"}}